Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 July 2021 | Story Xolisa Mnukwa | Photo Supplied
Mr Temba Hlasho, newly appointed Executive Director of Student Affairs.

The value proposition of the University of the Free State (UFS) Department of Student Affairs (DSA) is to create a socially just student-life experience that is conducive to student academic success, student engagement, and critical thinking.

Join the 2021 Virtual Student Affairs Week to learn more about UFS student support services

Student Affairs Week is an annual event that showcases the division’s wealth of student support departments – from Student Counselling and Development to Social Support to Student Governance – and many more useful support tools that students can make use of throughout their university careers. 

This initiative was established to improve an awareness and understanding of all Student Affairs divisions, and to also encourage participation in the programmes offered by the department. 

Student Affairs Week will run from 2 to 5 August 2021 on Blackboard, where students will be able to participate and engage according to their respective campuses. 
Students further stand a chance to win cash vouchers of up to R500 if they complete the Student Affairs quiz below.

UFS Bloemfontein Campus: Click here.
UFS Qwaqwa Campus: Click here.
UFS South Campus: Click here.

Message from the UFS Executive Director of Student Affairs 

According to the University of the Free State (UFS) Executive Director of Student Affairs, Temba Hlasho, a first-years’ experience at university is very critical for their academic journey. Hlasho encouraged students to be responsible, to continue to make themselves proud by embracing the privilege of being at university, and to continue to calibrate themselves into better persons for the South African society.

“To senior students, thank you for remaining loyal to the University of the Free State. Your perseverance and continued productive association with our institution will culminate into you becoming better future citizens,” Hlasho remarked. 
Hlasho further explained the division’s goal to ensure that students’ lived experiences on all three UFS campuses are equal and memorable through the diverse range of services and co-curricular activities offered. 

He further encouraged students to continue to adhere to COVID-19 safety protocols in order to preserve their health and livelihood.

For more information on Student Affairs Week, contact Annelize Visagie visagiea@ufs.ac.za 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept